Prothena Corporation (NASDAQ:PRTA) is a clinical-stage neuroscience company that discovers and develops novel therapies for ...

In the span of just 52 weeks, Target (NYSE: TGT) has traded as low as $87.35 per share and as high as $167.40 per share.

On May 22, Citi analyst Paul Lejuez lowered the firm’s price target on Target Corp. (NYSE: TGT) to $94 from $97, keeping a ...

Many investors were eager to see how retail giant Target's (NYSE: TGT) latest quarter would look, and, unfortunately, it wasn ...

Wells Fargo lowered its price target on Target Corp. (NYSE:TGT) to $115 from $135 but kept an Overweight rating on the shares ...

One of the largest and most important dairy farms in south-eastern Mexico, covering 1562ha in the state of Campeche, is on ...

Bernstein kept an Underperform rating on Target Corp. (NYSE:TGT) and lowered the associated price target to $80 from $82. The ...

Target (TGT 2.20%) has seen its stock price tumble approximately 30% year to date, underperforming the broader market by a ...

Fintel reports that on May 22, 2025, Telsey Advisory Group downgraded their outlook for Target (NYSE:TGT) from Outperform to ...

Bank of America downgrades Target (TGT) to Hold, citing market share losses, margin pressures, and near-term headwinds.

Check KVS Syllabus 2025 for PRT, TGT, and PGT posts. Get subject-wise syllabus, exam pattern, marking scheme, and preparation ...